DBH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DBH Antibodies for investigating Dipeptidyl Peptidase IV (DBH) in biological processes. DBH Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dipeptidyl Peptidase IV is an enzyme that regulates various physiological functions, including glucose metabolism and immune response. DBH plays a key role in inactivating incretin hormones, which are essential for insulin secretion and glucose homeostasis. The enzyme's involvement in modulating cell signaling pathways makes it particularly relevant for research in metabolic disorders. Scientists studying DBH can gain insights into its role in immune system regulation and metabolic processes. Research focusing on DBH continues to reveal new aspects of its function in normal physiology and disease states. Understanding DBH mechanisms can lead to improved therapeutic strategies for metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DBH and its impact on human health.